Clinical Immunodeficiency Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Immunodeficiency Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Immunodeficiency Program Today - Breaking & Trending Today

Pharming N : Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs) - Form 6-K -December 15, 2023 at 06:20 am EST

Published: December 15, 2023

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Source: marketscreener.com

Related Topics:

United KingdomNoord HollandUnited StatesCity OfGulbu UzelEthan MetelenisAnurag RelanHeather RobertsonV Koneti RaoMichael LevitanPharming GroupnvCommission File NumberPharming GroupInvestor Relations Corporate CommunicationsLifespring Life Sciences CommunicationNational Institutes Of HealthExchange CommissionDrug AdministrationSecurities ExchangeNational Institute Of AllergySenior Research PhysicianClinical Immunodeficiency ProgramVp Investor Relations Corporate CommunicationsBeth Israel Lahey HealthFile Number

Pharming To Develop Leniolisib For Additional PIDs Beyond APDS; Phase 2 Trial To Initiate In Q2

Published: December 13, 2023

Dutch biopharmaceutical company Pharming Group N.V. (PHAR) announced Wednesday its plans to develop leniolisib for additional primary immunodeficiencies or PIDs beyond activated phosphoinositide 3-kinase delta syndrome or APDS.

Source: rttnews.com

Related Topics:

Beth Israel Lahey HealthMore Such Health NewsClinical Immunodeficiency ProgramPharming GroupDrug AdministrationPhase 2 TrialPrimary ImmunodeficienciesHarming Leniolisib